SPDR S&P Pharmaceuticals ETF
XPH
XPH
72 hedge funds and large institutions have $101M invested in SPDR S&P Pharmaceuticals ETF in 2024 Q4 according to their latest regulatory filings, with 12 funds opening new positions, 26 increasing their positions, 14 reducing their positions, and 10 closing their positions.
Holders
72
Holders Change
+1
Holders Change %
+1.41%
% of All Funds
0.96%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
12
Increased
26
Reduced
14
Closed
10
Calls
$813K
Puts
$1.69M
Net Calls
-$877K
Net Calls Change
-$358K
Top Buyers
Top Sellers
1 |
CI
1
Clal Insurance
Tel-Aviv,
Israel
|
$0 |
2 |
2
Citigroup
New York
|
$43 |
3 |
RW
3
Rockport Wealth
Fairview Park,
Ohio
|
$0 |
4 |
GS
4
GTS Securities
New York
|
$0 |
5 |
5
Bank of America
Charlotte,
North Carolina
|
$11M |